 FLORHAM PARK, N.J., Aug. 16, 2021 GLOBE NEWSWIRE -- Celularity Inc. Celularity Nasdaq:CELU, a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic therapies, today reported financial results for the quarter ended June 30, 2021, and provided a summary of recent corporate highlights. 